Can an online game really improve blood sugar control for people with diabetes?

Follow me on Twitter @RobShmerling When it comes to serious health problems, you might think a game would be unlikely to help. But a recent study of people with diabetes could change your mind. Researchers publishing in the September 2017 issue of Diabetes Care describe a study in which people with diabetes joined a competitive online game aimed at educating participants about ways to improve blood sugar control. The results were encouraging. How a game led to improved blood sugars In this new research, 456 patients with poorly controlled diabetes were randomly assigned to one of two groups: Group 1 participated in an online or phone-based educational game that asked two questions about managing diabetes each week for six months. Later, answers and explanations were provided. This group also received a booklet about civics, including questions about citizenship in the US.* Group 2 received online or phone-based questions about civics each week for six months along with a booklet about diabetes self-management.* (*The researchers wanted to have a control group that was just like the diabetes management game group, except instead of diabetes information they provided information on civics. Both groups got a civics lesson and diabetes information; the only difference was how that information was delivered. That way investigators could say with more confidence it was the game that improved blood sugars.) Each participant was assigned to a team. Points were awarded for correct a...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Diabetes Health Source Type: blogs

Related Links:

Bigfoot Biomedical hasn't let the coronavirus pandemic stand in the way of bringing its injection-based digitized insulin dosing platform to the U.S. market. If anything, CEO Jeffrey Brewer says the pandemic has "only crystalized the need for medical solutions like ours that facilitate remote care, remote support, and home delivery." The company has raised a total of $55 million to close its series C equity financing. Abbott led the round with support from existing investors, including Quadrant Capital Advisors, Senvest Capital, Janus Henderson, and Cormorant Asset Management, along with n...
Source: MDDI - Category: Medical Devices Tags: Business R & D Source Type: news
CONCLUSION: SHED combined with HBO therapy was effective for treating type 2 diabetic rats. The underlying mechanism may involve SHED-mediated increase in the proliferation and trans-differentiation of islet β -cells and decrease in pro-inflammatory cytokines and apoptosis of islets.
Source: Clinics - Category: General Medicine Source Type: research
Conclusion FIB4A is a potential marker for early detection of NBNC-HCC in patients with diabetes mellitus. However, further studies are needed to confirm these findings.
Source: European Journal of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
Publication date: Available online 2 June 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Amerta Ghosh, Bhavya Arora, Ritesh Gupta, Shajith Anoop, Anoop Misra
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 2 June 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Timur Ekiz, Ahmet Cemal Pazarlı
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 2 June 2020Source: Canadian Journal of DiabetesAuthor(s): Sheri R. Colberg
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: Available online 21 March 2020Source: Canadian Journal of DiabetesAuthor(s): Chantal L. Lemieux, Margaret deGroh, Laurie Gibbons, Howard Morrison, Ying Jiang
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Publication date: September–October 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &Reviews, Volume 14, Issue 5Author(s): Hema S. Gopalan, Anoop Misra
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Have type 1 diabetes and being forced to work during the pandemic? Here are the legal resources to know about.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
Fractyl Laboratories is seeking to ‘turn back the clock’ in Type 2 diabetes progression with its disease-modifying therapy. FDA granted the Lexington, MA-based company IDE to launch a pivotal trial of the Revita DMR, a which holds the potential to eliminate the need for insulin injections in patients suffering from Type 2 diabetes. “Insulin is a challenging drug for patients with Type 2 diabetes because it can cause weight gain,” Harith Rajagopalan M.D. Ph.D., co-founder and CEO of Fractyl told MD+DI. “It can cause a risk of your bloo...
Source: MDDI - Category: Medical Devices Authors: Tags: Implants Regulatory and Compliance Source Type: news
More News: Blogging | Diabetes | Diets | Education | Endocrinology | Eyes | Harvard | Insulin | Internet | Lessons | Nutrition | Study | Sugar | Urology & Nephrology | Women